Post by
biorun on Jun 22, 2022 9:07am
Wuxi announcement
Looks like we are exactly where we were just before we took a ride to 0.60.
Essentially, they will scale up Anti-aging. I believe the likelihood of a big pharma coming on the scene to partner on anti-aging, just like Abbvie did with 1067, is now looking more plausible. And I would not be surprised at all if the fall brings some action and attention on a buy-out if there are at least 2 deals on table with this variant third budding through.